Dr SD Ravetkar, executive director, Serum Institute of India receives the BioSpectrum-ABLE award for BioPharma Company of the Year from Dr K VijayRaghavan, secretary, DBT
With a whopping 39 percent growth, Serum Institute of India (SII) retained its numero uno position in the Indian biotech industry recording revenues of `2,374 crore for 2012-13.
Serum was recognized with BioSpectrum-ABLE ‘BioPharma Company of the Year' at the 11th BioSpectrum Awards Nite on December 20, 2013, at the JW Marriott Hotel in Bangalore. Over 300 industry leaders at- tended the awards function.
BioSpectrum-ABLE Award Winners 2013
BioPharma Company 2013: Serum Institute of India
BioServices Company 2013: Syngene International India
BioAgri Company 2013: Nuziveedu Seeds